| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,780 | 1,860 | 22.06. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.05. | Kooth Digital Health Names Fred Bendaña Chief Commercial Officer | 371 | GlobeNewswire (Europe) | Chicago, May 21, 2026 (GLOBE NEWSWIRE) -- Kooth Digital Health announced the appointment of Fred Bendaña as Chief Commercial Officer, a role that will accelerate the growth of Soluna, Kooth's digital... ► Artikel lesen | |
| 19.05. | Kooth PLC - 2025 Annual Report and Notice of 2026 AGM | 1 | RNS | ||
| 19.05. | Kooth PLC - Directorate Change | - | RNS | ||
| 20.04. | Kooth PLC - 2025 Impact Report Shows Soluna's Continued Growth | 4 | RNS | ||
| 08.04. | Kooth reports lower revenue, earnings for 2025 | 14 | Sharecast | ||
| 08.04. | Kooth says annual earnings down but highlights "strong execution" | 2 | Alliance News | ||
| 08.04. | Kooth PLC Full Year Income Declines | 1 | RTTNews | ||
| KOOTH Aktie jetzt für 0€ handeln | |||||
| 08.04. | Kooth PLC - 2025 Full Year Results | 1 | RNS | ||
| 19.03. | Kooth PLC - Notice of Full Year Results | 3 | RNS | ||
| 12.03. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS | ||
| 02.03. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS | ||
| 11.02. | Kooth grants options to executives under long-term incentive plan | 3 | Investing.com | ||
| 11.02. | Kooth PLC - Awards under LTIP and PDMR dealing | - | RNS | ||
| 02.02. | Kooth PLC - Transfer of Treasury Shares & Exercise of Options | - | RNS | ||
| 28.01. | Broker tips: Energean, Kooth | 37 | Sharecast | ||
| 28.01. | Canaccord Genuity lowers target price on Kooth | 1 | Sharecast | ||
| 28.01. | Kooth PLC - Trading Update | - | RNS | ||
| 22.01. | Kooth PLC - $2.6m contract win with new US State | 1 | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,100 | +10,13 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 38,860 | -2,40 % | Truist Cuts Boston Scientific (BSX) 's Target as Doctors Change How They Use Its Heart Device | ||
| PAUL HARTMANN | 205,00 | -0,97 % | Dividendenbekanntmachungen (30.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 4IMPRINT GROUP PLC GB0006640972 1,194 GBP 1,3782 EUR AB DYNAMICS PLC GB00B9GQVG73 0,0308 GBP 0,0355 EUR AGNC INVESTMENT CORP US00123Q1040 0... ► Artikel lesen | |
| VOLITIONRX | 1,345 | -7,88 % | VolitionRx Limited: VolitionRx Announces Collaboration with Sysmex | HENDERSON, Nev., June 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration... ► Artikel lesen | |
| SYSMEX | 7,304 | -1,62 % | EQS-News: Sysmex Europe SE: Sysmex führt die HISCL Plattform ein, die schnelle, skalierbare Analysen aus Blut für die Alzheimerkrankheit ermöglicht | EQS-News: Sysmex Europe SE
/ Schlagwort(e): Produkteinführung/Sonstiges
Sysmex führt die HISCL Plattform ein, die schnelle, skalierbare Analysen aus Blut für die Alzheimerkrankheit... ► Artikel lesen | |
| EMBECTA | 2,740 | +1,29 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| ADDLIFE | 14,110 | 0,00 % | Dividendenbekanntmachungen (07.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCELLERON INDUSTRIES AG ADR US00449R1095 1,8766 USD 1,5973 EUR ACRINOVA AB SE0015660014 3,75 SEK 0,3453 EUR ACRINOVA AB B SE0015660030 3... ► Artikel lesen | |
| ENOVIS | 19,200 | +0,52 % | Enovis Corporation: Enovis Announces First Quarter 2026 Results | First-quarter sales growth of 5% on a reported basisFirst-quarter Reconstructive sales grew 11% on a reported basisReiterating full-year 2026 revenue, adjusted EBITDA, adjusted EPS, and Free Cash... ► Artikel lesen | |
| SI-BONE | 13,500 | -0,74 % | SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance | First Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2%U.S. revenue of $49.3 million, representing growth... ► Artikel lesen | |
| PULMONX | 1,100 | 0,00 % | Pulmonx Corporation: Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results | REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle CEO Walker, CFO Murray resign | ||
| PEIJIA MEDICAL | 0,430 | -0,92 % | Peijia Medical Announces 2025 Annual Results | SUZHOU, China, March 26, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| LIFECARE ASA | 0,013 | -56,67 % | Lifecare ASA: Share capital increase registered | ||
| BACTIGUARD | 1,345 | 0,00 % | Bactiguard Holding AB: Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting | At Bactiguard Holding AB's (publ) Annual General Meeting (AGM) on 19 May 2026, the following resolutions were made:
The AGM adopted the income statements and balance sheets for 2025 and decided that... ► Artikel lesen | |
| SCIBASE | 3,360 | -15,04 % | First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase | STOCKHOLM, June 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-powered skin health solutions, today announced that the first patient has been... ► Artikel lesen |